Digital PCR Market Size, Trends, Growth & Outlook

Digital PCR Market by Technology (Droplet Digital PCR (ddPCR) and BEAMing Digital PCR), Product Type (Digital PCR Equipment, Consumables & Reagents, and Software & Services), Application (Clinical diagnostics, Research, and Forensics), and End User (Clinical Diagnostic Laboratories, Pharmaceuticals and Biotechnology Industries, and University and Government Organizations): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Industry: Life Science | Report ID: FAMI-00212 | Published on: Sep, 2019 | View: 237 | Share:         

Request Sample Enquire Before Buying Request Discount

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

"The global digital polymerase chain reaction market generated $318 million in 2017, and is projected to reach $1,206 million by 2025, growing at a CAGR of 18.0% from 2018 to 2025. Digital polymerase chain reaction (dPCR) is an advancement of traditional polymerase chain reaction (PCR). The traditional PCR with its limited precision and accuracy often fail to amplify small samples of nucleic acid to a detectable level. As a result, there is a growing demand for better techniques to assess the minute quantities of DNA or RNA. dPCR is a more sensitive and reliable technique with improved ability to quantify the absolute amount of nucleic acid. It divides the sample into large number of fragments, each containing either one or no template nucleic acid sequence. After DNA amplification, scoring is done with the help of fluorescence, counting the score as positive for the fraction containing template sequence and negative for the sample without the template sequence.

The major factors driving the global digital polymerase chain reaction market are increase in demand for innovative diagnostic techniques, rise in disease awareness, need for early diagnosis of viral, infectious, and genetic disease, and surge in number of diagnostic centers across the globe. However, high cost of dPCR testing and limited expertise and accessibility, especially in the developing countries are expected to restrict the market growth.

The global digital polymerase chain reaction (dPCR) market is segmented on the basis of technology, type, application, end user, and region. According to technology, the market is bifurcated into droplet digital PCR (ddPCR) and BEAMing digital PCR. On the basis of type, the market is divided into digital PCR equipment, consumables & reagents, and software & services. Based on application, it is categorized into clinical diagnostics, research and others. On the basis of end user, the market is segmented into clinical diagnostic laboratories, pharmaceuticals and biotechnology industries, and university and government organizations. Based on region, it is analyzed across  North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Digital PCR Market:

    This report offers a detailed quantitative analysis of the current market trends from 2018 to 2025 to identify the prevailing opportunities.

    The market estimations provided in this report are based on a comprehensive analysis of the key developments in the industry.

    In-depth analysis based on region facilitates in analyzing the regional market to assist in strategic business planning.

    The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

Digital PCR Key Market Segments:

By Technology

    Droplet Digital PCR (ddPCR)
    BEAMing Digital PCR

By Product Type

    Digital PCR equipment
    Consumables and reagents
    Software & Services

By Application

    Clinical diagnostics
    Research
    Forensics

By End User

    Clinical diagnostic laboratories
    Pharmaceuticals and biotechnology industries
    University and government organizations

By Region

    North America
        U.S.
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Rest of Europe
    Asia-Pacific
        Japan
        China
        Australia
        India
        South Korea
        Taiwan
        Rest of Asia-Pacific
    LAMEA
        Brazil
        Saudi Arabia
        South Africa
        Rest of LAMEA

Key Players Profiled

    Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.)
    Expedeon AG
    Fluidigm Corporation
    JN Medsys
    Merck KGaA
    Qiagen N.V. (Formulatrix, Inc.)
    Stilla Technologies
    Sysmex Corporation (Sysmex Inostics GmbH)
    Thermo Fisher Scientific, Inc."
 

Get a sample pages of this report Click here

"CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Porters five forces analysis
3.4. Top player positioning, 2017
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rise in prevalence of infectious diseases and cancer
3.5.1.2. Increase in awareness and acceptance of personalized medicines
3.5.1.3. Technological Advancements

3.5.2. Restraints

3.5.2.1. High cost of digital PCR devices
3.5.2.2. Reimbursement issues

3.5.3. Opportunity

3.5.3.1. Increase in funding for R&D activities

CHAPTER 4: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY

4.1. Overview

4.1.1. Market size and forecast

4.2. Droplet Digital PCR

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. BEAMing Digital PCR

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Consumables and reagents

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Digital PCR equipment

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Software & services

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

CHAPTER 6: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Research

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Clinical diagnostics

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

6.4. Forensics

6.4.1. Market size and forecast
6.4.2. Market analysis, by country

CHAPTER 7: DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Clinical diagnostic laboratories

7.2.1. Market size and forecast
7.2.2. Market analysis, by country

7.3. Pharmaceuticals & biotechnology industries

7.3.1. Market size and forecast
7.3.2. Market analysis, by country

7.4. University & research organizations

7.4.1. Market size and forecast
7.4.2. Market analysis, by country

CHAPTER 8: DIGITAL PCR MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends and opportunities
8.2.2. North America digital PCR market, by country

8.2.2.1. U.S. digital PCR market, by technology
8.2.2.2. U.S. digital PCR market, by type
8.2.2.3. U.S. digital PCR market, by application
8.2.2.4. U.S. digital PCR market, by end user
8.2.2.5. Canada digital PCR market, by technology
8.2.2.6. Canada digital PCR market, by type
8.2.2.7. Canada digital PCR market, by application
8.2.2.8. Canada digital PCR market, by end user
8.2.2.9. Mexico digital PCR market, by technology
8.2.2.10. Mexico digital PCR market, by type
8.2.2.11. Mexico digital PCR market, by application
8.2.2.12. Mexico digital PCR market, by end user

8.2.3. North America digital PCR market, by technology
8.2.4. North America digital PCR market, by type
8.2.5. North America digital PCR market, by application
8.2.6. North America digital PCR market, by end user

8.3. Europe

8.3.1. Key market trends and opportunities
8.3.2. Europe digital PCR market, by country

8.3.2.1. Germany digital PCR market, by technology
8.3.2.2. Germany digital PCR market, by type
8.3.2.3. Germany digital PCR market, by application
8.3.2.4. Germany digital PCR market, by end user
8.3.2.5. France digital PCR market, by technology
8.3.2.6. France digital PCR market, by type
8.3.2.7. France digital PCR market, by application
8.3.2.8. France digital PCR market, by end user
8.3.2.9. UK digital PCR market, by technology
8.3.2.10. UK digital PCR market, by type
8.3.2.11. UK digital PCR market, by application
8.3.2.12. UK digital PCR market, by end user
8.3.2.13. Italy digital PCR market, by technology
8.3.2.14. Italy digital PCR market, by type
8.3.2.15. Italy digital PCR market, by application
8.3.2.16. Italy digital PCR market, by end user
8.3.2.17. Spain digital PCR market, by technology
8.3.2.18. Spain digital PCR market, by type
8.3.2.19. Spain digital PCR market, by application
8.3.2.20. Spain digital PCR market, by end user
8.3.2.21. Rest of Europe digital PCR market, by technology
8.3.2.22. Rest of Europe digital PCR market, by type
8.3.2.23. Rest of Europe digital PCR market, by application
8.3.2.24. Rest of Europe digital PCR market, by end user

8.3.3. Europe digital PCR market, by technology
8.3.4. Europe digital PCR market, by type
8.3.5. Europe digital PCR market, by application
8.3.6. Europe digital PCR market, by end user

8.4. Asia-Pacific

8.4.1. Key market trends and opportunities
8.4.2. Asia-Pacific digital PCR market, by country

8.4.2.1. Japan digital PCR market, by technology
8.4.2.2. Japan digital PCR market, by type
8.4.2.3. Japan digital PCR market, by application
8.4.2.4. Japan digital PCR market, by end user
8.4.2.5. China digital PCR market, by technology
8.4.2.6. China digital PCR market, by type
8.4.2.7. China digital PCR market, by application
8.4.2.8. China digital PCR market, by end user
8.4.2.9. Australia digital PCR market, by technology
8.4.2.10. Australia digital PCR market, by type
8.4.2.11. Australia digital PCR market, by application
8.4.2.12. Australia digital PCR market, by end user
8.4.2.13. India digital PCR market, by technology
8.4.2.14. India digital PCR market, by type
8.4.2.15. India digital PCR market, by application
8.4.2.16. India digital PCR market, by end user
8.4.2.17. South Korea digital PCR market, by technology
8.4.2.18. South Korea digital PCR market, by type
8.4.2.19. South Korea digital PCR market, by application
8.4.2.20. South Korea digital PCR market, by end user
8.4.2.21. Taiwan digital PCR market, by technology
8.4.2.22. Taiwan digital PCR market, by type
8.4.2.23. Taiwan digital PCR market, by application
8.4.2.24. Taiwan digital PCR market, by end user
8.4.2.25. Rest of Asia-Pacific digital PCR market, by technology
8.4.2.26. Rest of Asia-Pacific digital PCR market, by type
8.4.2.27. Rest of Asia-Pacific digital PCR market, by application
8.4.2.28. Rest of Asia-Pacific digital PCR market, by end user

8.4.3. Asia-Pacific digital PCR market, by technology
8.4.4. Asia-Pacific digital PCR market, by type
8.4.5. Asia-Pacific digital PCR market, by application
8.4.6. Asia-Pacific digital PCR market, by end user

8.5. LAMEA

8.5.1. Key market trends and opportunities
8.5.2. LAMEA digital PCR market, by country

8.5.2.1. Brazil digital PCR market, by technology
8.5.2.2. Brazil digital PCR market, by type
8.5.2.3. Brazil digital PCR market, by application
8.5.2.4. Brazil digital PCR market, by end user
8.5.2.5. Saudi Arabia digital PCR market, by technology
8.5.2.6. Saudi Arabia digital PCR market, by type
8.5.2.7. Saudi Arabia digital PCR market, by application
8.5.2.8. Saudi Arabia digital PCR market, by end user
8.5.2.9. South Africa digital PCR market, by technology
8.5.2.10. South Africa digital PCR market, by type
8.5.2.11. South Africa digital PCR market, by application
8.5.2.12. South Africa digital PCR market, by end user
8.5.2.13. Rest of LAMEA digital PCR market, by technology
8.5.2.14. Rest of LAMEA digital PCR market, by type
8.5.2.15. Rest of LAMEA digital PCR market, by application
8.5.2.16. Rest of LAMEA digital PCR market, by end user

8.5.3. LAMEA digital PCR market, by technology
8.5.4. LAMEA digital PCR market, by type
8.5.5. LAMEA digital PCR market, by application
8.5.6. LAMEA digital PCR market, by end user

CHAPTER 9: COMPANY PROFILES

9.1. BIO-RAD LABORATORIES, INC. (RAINDANCE TECHNOLOGIES, INC.)

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments

9.2. EXPEDEON AG

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance

9.3. FLUIDIGM CORPORATION

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance

9.4. JN MEDSYS

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Key strategic moves and developments

9.5. MERCK KGAA

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. QIAGEN N.V. (FORMULATRIX, INC.)

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments

9.7. STILLA TECHNOLOGIES

9.7.1. Company overview
9.7.2. Company snapshot

9.8. SYSMEX CORPORATION (SYSMEX INOSTICS GMBH)

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Business performance

9.9. THERMO FISHER SCIENTIFIC, INC.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance"
 

Select License Type
  • Single User License $5370 USD
  • Multi-User License $6450 USD
  • Corporate User License $8995 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.